Levodopa Concentration Profile After Repeated Doses of Different Stalevo Strengths With 3.5 Hours Dosing Frequency; an Open, Randomised, Crossover, Levodopa/Carbidopa Controlled Single Centre Study in Healthy Subjects, Two Parallel Groups.

Trial Profile

Levodopa Concentration Profile After Repeated Doses of Different Stalevo Strengths With 3.5 Hours Dosing Frequency; an Open, Randomised, Crossover, Levodopa/Carbidopa Controlled Single Centre Study in Healthy Subjects, Two Parallel Groups.

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Sep 2011

At a glance

  • Drugs Levodopa/carbidopa; Levodopa/carbidopa/entacapone
  • Indications Dystonia; Parkinson's disease
  • Focus Pharmacokinetics
  • Acronyms NEWSTA
  • Sponsors Orion
  • Most Recent Events

    • 12 Aug 2010 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
    • 12 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top